Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
71.86
+2.68 (3.87%)
At close: Mar 9, 2026, 4:00 PM EDT
70.51
-1.35 (-1.88%)
After-hours: Mar 9, 2026, 7:43 PM EDT
Inhibrx Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 153.09 | 152.6 | 277.92 | - | 131.3 |
| Cash & Short-Term Investments | 153.09 | 152.6 | 277.92 | - | 131.3 |
| Cash Growth | -22.03% | -45.09% | - | - | - |
| Accounts Receivable | 0.11 | 0.4 | 0.78 | 0.24 | - |
| Other Receivables | 0.73 | 0.02 | - | 0.01 | - |
| Receivables | 0.84 | 0.42 | 0.78 | 0.26 | - |
| Inventory | 2.25 | 2 | 9.89 | 0.81 | - |
| Prepaid Expenses | 3.55 | 4.19 | 5.67 | 4.53 | - |
| Other Current Assets | 1.7 | 1.2 | 1.09 | 0.67 | 7.81 |
| Total Current Assets | 161.42 | 160.4 | 295.36 | 6.26 | 139.11 |
| Property, Plant & Equipment | 10.31 | 13.54 | 9.37 | 7.22 | - |
| Other Long-Term Assets | 5.74 | 6.83 | 3.16 | 3.16 | 11.34 |
| Accounts Payable | 12.69 | 14.89 | 33.76 | 9.45 | - |
| Accrued Expenses | 21.05 | 24.25 | 20.49 | 9.46 | - |
| Current Portion of Leases | 2.25 | 1.6 | 2.06 | 1.86 | - |
| Other Current Liabilities | - | - | - | - | 22.45 |
| Total Current Liabilities | 35.98 | 40.73 | 56.31 | 20.77 | 22.45 |
| Long-Term Debt | 99.92 | - | 206.97 | - | 70.47 |
| Long-Term Leases | 4.74 | 6.45 | 1.11 | 3.17 | - |
| Other Long-Term Liabilities | - | - | - | - | 5.14 |
| Common Stock | 0 | 0 | 0.01 | -7.3 | 52.38 |
| Additional Paid-In Capital | 250.18 | 239.72 | 657.23 | - | - |
| Retained Earnings | -213.35 | -106.13 | -613.73 | - | - |
| Total Liabilities & Equity | 177.47 | 180.77 | 307.89 | 16.65 | 150.45 |
| Total Debt | 106.91 | 8.05 | 210.14 | 5.03 | 70.47 |
| Net Cash (Debt) | 46.18 | 144.55 | 67.78 | -5.03 | 60.83 |
| Net Cash Growth | -76.25% | 113.25% | - | - | - |
| Net Cash Per Share | 2.98 | 9.65 | 5.75 | -0.13 | 1.60 |
| Filing Date Shares Outstanding | 14.54 | 14.48 | 11.78 | 40.11 | 38.58 |
| Total Common Shares Outstanding | 14.5 | 14.48 | 11.78 | 40.11 | 38.58 |
| Working Capital | 125.44 | 119.67 | 239.05 | -14.51 | 116.66 |
| Book Value Per Share | 2.54 | 9.23 | 3.69 | -0.18 | 1.36 |
| Tangible Book Value | 36.83 | 133.58 | 43.5 | -7.3 | 52.38 |
| Tangible Book Value Per Share | 2.54 | 9.23 | 3.69 | -0.18 | 1.36 |
| Machinery | 10.1 | 10.31 | 9.02 | 7.55 | - |
| Construction In Progress | - | - | 3.59 | - | - |
| Leasehold Improvements | 0.8 | 0.8 | 0.44 | 0.44 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.